Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

 Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

Shots:

  • Janssen gets license to utilize physIQ’s accelerateIQ platform to gather data from clinical studies through different wearable biosensors. The platform is powered by FDA-cleared digital biomarkers that helps to transform raw data into clinical insight
  • The platform’s findings can be used to advance subsequent research projects and will support both R&D and commercial strategies
  • The collaboration will boost the ability to bring new treatments to market and enable commercial strategies that integrate digital medicine into patient care

Click here to­ read full press release/ article | Ref: Business Wire | Image: Business Wire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post